Further, the ovarian cancer dataset from Kaplan Meier Plotter was used to test for the survival prediction capacity of PIK3C2B, and we found that PIK3C2B is associated with poor overall survival and progression free survival in endometrioid ovarian cancer patients but not in HGSOC (Figure 1E,F and Figure S1D). This evidence concerns the gene PIK3C2B and ovarian endometrioid adenocarcinoma.